The invention involves methods for characterizing an individual's risk profile of developing a future cardiovascular disorder by obtaining a level of the marker of systemic inflammation in the individual. The invention also involves methods for evaluating the likelihood that an individual will benefit from treatment with an agent for reducing the risk of future cardiovascular disorder.

 
Web www.patentalert.com

< Heterocyclic compounds

< Pyridinyl derivatives for the treatment of depression

> Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins

> Propanolaminotetralines, preparation thereof and compositions containing same

~ 00254